Healthcare - Biotechnology - NASDAQ - US
$ 3.29
-4.64 %
$ 9.87 M
Market Cap
3.13
P/E
CASH FLOW STATEMENT
-9.56 M
OPERATING CASH FLOW
0
INVESTING CASH FLOW
5.97 M
FINANCING CASH FLOW
FREE CASH FLOW ANALYSIS
Free Cash Flow Analysis
Kiora Pharmaceuticals, Inc.
| Net Income | -12.5 M |
| Depreciation & Amortization | 62.4 K |
| Capital Expenditures | 1 |
| Stock-Based Compensation | 755 K |
| Change in Working Capital | -1.82 M |
| Others | 2.86 M |
| Free Cash Flow | -9.56 M |
Cash Flow
Millions
| Dec-2023 | Dec-2022 | Dec-2021 | Dec-2020 | Dec-2019 | Dec-2018 | Dec-2017 | Dec-2016 | Dec-2015 | Dec-2014 | Dec-2013 | Dec-2012 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| OPERATING CASH FLOW | ||||||||||||
| Net Income | (12.5) | (13.6) | (16.4) | (8.1) | (7.1) | (10.8) | (13.2) | (13.3) | (8.4) | (1.6) | (3.7) | (5.8) |
| Depreciation & Amortization | 62.4 K | 41.6 K | 45.3 K | 33.4 K | 0.2 | 38.5 K | 19.3 K | 5.18 K | 1.26 K | 1.72 K | 5.46 K | 9.09 K |
| Deferred Income Tax | 90.3 K | (0.1) | (0.3) | 12.1 K | 95.4 K | 86 K | (1.3) | (0.5) | 0 | 0.2 | 0 | 0 |
| Stock Based Compensation | 0.8 | 0.5 | 0.8 | 0.7 | 0.9 | 0.9 | 0.9 | 0.5 | 1.2 | 26.8 K | 0.2 | 0.4 |
| Other Operating Activities | 3.9 | 2.1 | 6.0 | 0.3 | 0.5 | 2.3 | 91.1 K | 0.5 | 1.7 | (1.1) | 0.5 | 5.12 K |
| Change in Working Capital | (1.8) | 0.7 | (1.0) | (0.3) | (2.7) | (1.0) | 7.1 | 4.4 | 1.0 | 1.5 | 2.22 K | 0.2 |
| Cash From Operations | (9.6) | (10.4) | (10.9) | (7.3) | (8.2) | (10.8) | (6.5) | (8.4) | (4.5) | (1.0) | (3.0) | (5.2) |
| INVESTING CASH FLOW | ||||||||||||
| Capital Expenditures | 1 | 0 | 63.9 K | (0.1) | 0 | (0.3) | 37 K | 11 K | 0 | 0 | 0 | 0 |
| Other Items | 1 | 6.38 K | 93.2 K | (0.1) | 0 | 0 | 0 | 0.2 | 20 K | 0 | 0 | 0 |
| Cash From Investing Activities | 0 | 6.38 K | (0.2) | (0.2) | 0 | (0.3) | 37 K | 0.1 | 20 K | 0 | 0 | 0 |
| FINANCING CASH FLOW | ||||||||||||
| Common Stock Repurchased | 0 | 15.6 K | 0 | 0 | 2.61 K | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Debt Repaid | 0 | 0 | (0.2) | 0.3 | 0 | 0 | 0 | 2.86 K | 0 | 1.8 | 1.5 | 34.2 K |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities | (0.2) | 3.3 | 50 K | (0.3) | 2.0 | 1.2 | 82.2 K | (0.3) | (1.5) | (1.1) | 1.32 K | (0.1) |
| Cash From Financing Activities | 6.0 | 8.6 | 17.8 | 5.0 | 3.9 | 11.3 | 10.7 | 3.5 | 12.6 | 0.6 | 1.5 | 75.4 K |
| CHANGE IN CASH | ||||||||||||
| Net Change In Cash | (3.6) | (1.9) | 6.7 | (2.6) | (4.2) | 0.2 | 4.2 | (4.8) | 8.2 | (0.3) | (1.5) | (5.3) |
| FREE CASH FLOW | ||||||||||||
| Free Cash Flow | (9.6) | (10.4) | (11.0) | (7.5) | (8.2) | (11.1) | (6.5) | (8.4) | (4.5) | (1.0) | (3.0) | (5.2) |